2017 Seminar in Forensic Toxicology Faculty Page
Wendy Adams, PhD, F-ABFT Assistant Laboratory Director & Forensic Toxicologist, NMS Labs
Wendy Adams is an Assistant Laboratory Director with NMS Labs in Willow Grove, Pennsylvania. She earned her Ph.D. in Pharmacology and Toxicology from Duquesne University in 2007. Her work experience includes Synthetic Chemistry at Systems Integrated Drug Discovery Co., Forensic Chemistry at the Allegheny County Coroner's Office and Analytical Chemistry in the GC/MS Screening Department at NMS Labs. She has extensive testimony experience in impaired driving cases, including rare substances such as difluoroethane. She currently directs diverse departments covering drugs of abuse by GC/MS and LC-MS/MS, screening by immunoassay and LC/TOF and special chemistry.
Michael Ashburn, MD, MPH, MBA Director, Pain Medicine, Penn Pain Medicine Center
Dr. Ashburn is professor of Anesthesiology and Critical Care, and a Senior Fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He is the Director of the Penn Pain Medicine Center, and was named to the Penn Academy of Master Clinicians in 2014.
Dr. Ashburn completed his undergraduate training at Auburn University in physics, his Masters in Public Health at the University of Utah, Masters in Business Administration at the Wharton School of Business at the University of Pennsylvania, and his medical training at the University of South Alabama in Mobile, Alabama. He completed his residency in anesthesiology at the University of South Alabama Medical Center, and a fellowship in pain medicine at the University of Utah. He is board certified in Anesthesiology, Pain Management, and Hospice and Palliative Medicine through the American Board of Anesthesiology.
Dr. Ashburn was a member of the Department of Anesthesiology at the University of Utah from 1987 – 2002, and served as Professor of Anesthesiology and Director of the Pain Management Center from 1996 - 2002. Dr. Ashburn was president of the American Pain Society from 2000 - 2002. In addition, Dr. Ashburn served on the Board of Directors of the Rehabilitation Accreditation Commission, (CARF) from 2001-2003, where he served as a member of 3 National Advisory Committees on Pain. Prior to joining the faculty at the University of Pennsylvania in 2007, Dr. Ashburn was the co-founder and Executive Vice President for Clinical and Regulatory Affairs for ZARS Pharma of Salt Lake City.
Dr. Ashburn was a Robert Wood Johnson Health Policy Fellow from 1995 - 1996, where he served as a health policy advisor for Senator Orrin Hatch (R, UT) in Washington, DC. He served as the Chairman of the Pain Care Coalition from 2000-2002, and as the chair of the Pennsylvania Pain Coalition from 2009 to 2012. Dr. Ashburn has served as a consultant to the Drug Enforcement Agency, Federal Bureau of Investigation, Department of Justice, and the Food and Drug Administration.
Dr. Ashburn served on the Pennsylvania House Advisory Committee on Opioid Addiction in 2014 and 2015, currently serves on the Pennsylvania State Task Force on Prescription Drug Abuse, and the Pennsylvania Legislative Advisory Committee on Addiction Treatment Services. Dr. Ashburn is also a member of the Pennsylvania prescription drug monitoring program advisory board. Dr. Ashburn recently served on a Pennsylvania task force to develop a state-wide core competencies for the prevention and management of prescription drug abuse for use by Pennsylvania medical schools.
Dr. Ashburn serves on the editorial board for Pain Medicine and The Journal of Opioid Management. He has been active in clinical research, mainly centered on the development of outcome measurement systems for chronic pain and palliative care, the integration of specialty care into primary care practice through the patient-centered medical home model of care, the study of non-invasive drug delivery systems, and the conduct of safety and efficacy trials intended to evaluate a drug or device for the treatment of pain.
Nadia I. Awad, PharmD, BCPS
Emergency Medicine Pharmacist, Robert Wood Johnson University Hospital
Dr. Nadia I. Awad is an emergency medicine pharmacist at Robert Wood Johnson University Hospital in New Brunswick, NJ. After obtaining her Bachelor of Arts degree in Biological Sciences from Rutgers College in 2007, and earning her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers University in 2011, she completed two years of post-graduate residency training at Robert Wood Johnson University Hospital, specializing in emergency medicine pharmacy. She is board certified in pharmacotherapy. In addition, she is the associate editor of the blog, Emergency Medicine PharmD (http://empharmd.blogspot.com), and she has authored over 75 educational entries related to the application of pharmacotherapy in the emergency department since its launch in 2012, which currently garners approximately 50,000 views per month from an international audience. Dr. Awad is also part of a national collaborative effort of emergency medicine pharmacists involved in the creation of an online educational curriculum known as the CAPSULES series (www.aliemu.com/capsules- series), which is aimed to focus on practical pharmacology for the emergency medicine practitioner. In addition, she has authored over 15 peer-reviewed journal articles and research abstracts. Her research interests include emergency medicine, toxicology, disaster preparedness, acute neurocritical care, and social media in pharmacy education. She can be followed on Twitter at @Nadia_EMPharmD.
Joan Orsini Ford, JD
Medical Malpractice Lawyer, Marshall Dennehey
Joan joined the law firm of Marshall Dennehey in 1997. As a member of the Health Care Department, she concentrates in litigation involving hospitals, nursing homes, long-term care facilities, residential facilities, physicians, nurses and dentists, as well as other health care issues.
After spending a year in Jakarta, Indonesia, as a foreign exchange student, Joan attended LaSalle University, where she earned her Bachelor of Arts degree in 1984. She then attended Widener University School of Law where she earned her juris doctor in December 1986. Joan's legal education also included courses at Notre Dame School of Law, London, England, and The Dickenson Law School, Florence, Italy.
Since completing her education, Joan has focused her practice on the field of medical litigation. After graduation, she first worked at O'Brien & Ryan, where her practice concentrated on the defense of medical malpractice cases.
Scott Frame, JD
Assistant District Attorney, Major Crimes Unit, Trials Division, Montgomery County District Attorney's Office
Scott Frank Frame is an attorney based out of Norristown, PA. Prior to going to law school, Mr. Frame enlisted in the United States Army, entering as a Private and working his way up through the ranks to Sergeant. In 2009, he deployed to Iraq where served as a Joint Node Network Systems Operator-Maintainer. During his time in the military, Mr. Frame enrolled at Thomas Edison State College and completed a four (4) year Bachelor of Arts degree. While deployed, Mr. Frame was accepted into the J.D. program at Widener University School of Law located in Wilmington, DE. Mr. Frame started at Widener and was immediately elected a Student Bar Association Representative for his 1L class. During his time at Widener, Mr. Frame wrote on to the Widener Journal of Law, Economics & Race and was chosen to be the Assistant Editor-in-Chief during his 3L year. He was also chosen to be part of the prestigious Moe Levine Trial Advocacy Honor Society where he participated on the School’s Trial Team. He graduated with certificates in both Criminal Law and Trial Advocacy.
During his 3L year, Mr. Frame applied to and was selected to a Master’s program at Temple University Beasley School of Law. He started the program while studying for the bar and continued throughout his year, eventually graduating with honors. During his 1L year, Mr. Frame began an internship with the Montgomery County District Attorney’s Office, where he works to this day. He was assigned to assist the Captain of Sex Crimes during his first summer, and to the Pre-Trials Division his second. During this second and third years, he tried summary trials, ICC’s, and probation violation hearings for the
After taking the bar, Mr. Frame was hired as a Special Assistant District Attorney where he served in the Pre-Trials Unit. In 2014, Mr. Frame was promoted to the Trials division and reassigned to the Juvenile Unit. Later that year, he was again promoted and reassigned to the County’s New DUI Court, where he spent approximately two years learning the complexities of DUI law. After the DUI Court ended in Montgomery County, Mr. Frame was reassigned to a brief stint on the Economic Crimes Unit, where he prosecuted credit card fraud, thefts, and white collar crime.
For the last year and a half, Mr. Frame has been assigned to the Major Crimes Unit, where he prosecutes burglaries, robberies, aggravated assaults, and attempted homicides. He still maintains a caseload of Economic Crime and DUI cases. During his career, he has tried close to 100 bench trials and 6 jury trials to verdict. Mr. Frame was married to his beautiful wife Christina in 2013 and they have a son together, Gerald Frank Frame, who is almost 2 years old.
James R. Gill, MD
Chief Medical Examiner, Connecticut Office of the Chief Medical Examiner; Clinical Assistant Professor, Department of Pathology, Yale
Dr. Gill is the Chief Medical Examiner of Connecticut and a Clinical Assistant Professor in the Department of Pathology at Yale. He is a graduate of M.I.T. and the University of Connecticut School of Medicine. He did his pathology training at Yale and Memorial Sloan-Kettering Cancer Center and his forensic pathology fellowship at the New York City Office of Chief Medical Examiner. Prior to Connecticut, he was the Deputy Chief Medical Examiner for Bronx County in New York City. He is a member of NAME, the American Academy of Forensic Sciences, the College of American Pathologists (Forensic Pathology Committee), and the forensic pathology test-writing committee for the American Board of Pathology. He serves on the editorial boards of the Journal of Forensic Sciences, Academic Forensic Pathology, and Forensic Science, Medicine, and Pathology.
Mike Greenberg, MD, MPH, FACMT
Emergency Medicine Physician, Drexel University College of Medicine
Dr. Greenberg is a tenured professor of emergency medicine and a professor of public health at Drexel University College of Medicine in Philadelphia, and a clinical professor of emergency medicine at Temple University School of Medicine. He is the former program director for the Medical Toxicology Fellowship at Drexel, where he also serves as the chief of the Division of Medical Toxicology.
He has served as an instructor in the Department of Defense Domestic Preparedness Program and as a consultant regarding chemical and biological weapons of mass destruction to the U.S. State Department`s Bureau of Diplomatic Security and the U.S. Navy`s Office of Homeland Defense.
Dr. Michael Greenberg's primary clinical practice involves medical, occupational and environmental toxicology. He has served as a clinical consultant for the Philadelphia Poison Control Center since 1994. He served as a medical officer with the United States Marine Corps Reserve while in the United States Naval Reserve from 1985 to 1995, and served on active duty during Operation Desert Storm.
Michael Holland, MD, FAACT, FACMT, FACOEM, FACEP
Senior Medical Toxicologist, Center for Toxicology and Environmental Health; Clinical Associate Professor, Department of Emergency Medicine, SUNY Upstate Medical University
Dr. Holland is a Senior Medical Toxicologist at Center for Toxicology and Environmental Health (CTEH). He also serves as the Director of Occupational Medicine at the Glens Falls Hospital Center for Occupational Health, and Clinical Associate Professor at SUNY Upstate Medical University. He is also Consulting Medical Toxicologist at the Upstate New York Poison Center in Syracuse, NY. Dr. Holland has over 30 years of experience within Occupational Medicine and Toxicology fields. He conducts toxicological evaluations, human health and ecological risk assessments, community and worker health evaluations, and regulatory compliance consultations. His expertise includes Emergency Medicine, Medical Toxicology, and Occupational Medicine. He has also served as the Medical Unit Leader with an Incident Command Structure (ICS) doing large-scale chemical emergency responses.
Dr. Holland is a member of the American College of Medical Toxicology. He has Fellowship Status Awards from the American College of Medical Toxicology, American College of Emergency Physicians, American College of Occupational and Environmental Medicine and the American Academy of Clinical Toxicology. He currently serves on a variety of Boards and Committees, including: Board of Directors of the American College of Occupational and Environmental Medicine (ACOEM), and the Medical Review Officer Certification Council (MROCC); Committee work for the American Industrial Hygiene Association (AIHA) Emergency Response Planning Committee, and the American Academy of Clinical Toxicology Occupational Toxicology Committee. He is also Regional Medical Director for New England states for the Advanced HazMat Life Support (AHLS), and has been an AHLS instructor since 2003.
Sherri Kacinko, PhD
Sherri Kacinko earned her Bachelor of Science Degree in Chemistry at the University of Pittsburgh in Johnstown, PA and took graduate classes in forensic science at George Washington University. She performed pharmaceutical quality control at Lancaster Laboratories in Lancaster, PA. After spending 3 years working as a crime laboratory analyst in the chemistry section of the Florida Department of Law Enforcement Orlando Regional Operations Center she returned to graduate school and received her Doctor of Philosophy in Toxicology at the University of Maryland-Baltimore. She is now a toxicologist at NMS Labs in Willow Grove, PA. Dr. Kacinko is also adjunct faculty in the chemistry department at Arcadia University and serves as an Instructor at the Center for Forensic Science Research & Education. In this role, Sherri lectures in postmortem forensic toxicology and human performance toxicology courses. Her current research interests include the identification and quantification of novel psychoactive substances including synthetic cannabinoids, stimulants, hallucinogens, opioids and benzodiazepines in biological fluids and their toxicological impact.
Sherri is Board Certified by the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists, the International Association of Forensic Toxicologists and the American Academy of Forensic Sciences. Sherri was presented with the American Academy of Forensic Sciences Toxicology Section Irving Sunshine Award in recognition of early career research.
Barry Logan, PhD, DABFT
Sr. Vice President, Forensic Science Initiatives and Chief of Forensic Toxicology, NMS Labs; Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Foundation
Dr. Barry K. Logan is Sr. Vice President of Forensic Science Initiatives, Chief Scientist, at NMS Labs in Willow Grove, Pennsylvania, where his responsibilities include management of toxicology resources, new test design and development, and expert testimony in forensic toxicology and chemistry.
Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over one hundred (100) publications and four hundred (400) presentations in forensic toxicology and analytical chemistry, including work on the effects of methamphetamine, cocaine and marijuana on drivers, drug caused and related death.
His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs.
Dr. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and Executive Director at the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in suburban Philadelphia. He holds academic appointments at Indiana University, Arcadia University and Thomas Jefferson University.
In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and in 2013-14 served as President of the American Academy of Forensic Sciences (AAFS).
Charles McKay, MD, FACMT
After graduating from both Dartmouth College and Medical School, Dr. McKay completed an internship and residency in Internal Medicine at Rhode Island Hospital. He completed his residency in Emergency Medicine at Denver General Hospital, and completed practice pathway preceptorships in Medical Toxicology at the Rocky Mountain and New York Poison Control Centers.
Dr. McKay is a medical toxicologist at Hartford Hospital and the University of Connecticut School of Medicine, where he is an Associate Professor of Emergency Medicine. He is a diplomat of the ABMT and the ABMS Toxicology Subboard. He is the Associate Medical Director of the Connecticut Poison Control Center and the Director of the Toxicology Fellowship at UConn. Dr. McKay also directs a toxicology consult service at Hartford Hospital and Connecticut Children’s Medical Center (CCMC). As Medical Director of Occupational Health Services for Hartford Hospital and CCMC, he also evaluates questions of workplace safety and toxic exposure for 9,000 employees.
He has served on the ACMT Board of Directors since 2007 and is the Past Chair of the ACMT Practice Committee. Dr. McKay is active in biopreparedness efforts at the local and state level and has helped lead ACMT’s participation in the Department of Homeland Security’s Chemical Terrorism Risk Assessment (CTRA) process. Dr. McKay is also the National Coordinator of the ACMT-ATSDR Regional Consultation Network.
Dr. McKay seeks “to develop sustainable practice opportunities for medical toxicologists.” His interests lie in clinical patient care, occupational and environmental toxicology, biopreparedness, and training of residents and fellows. He also enjoys scuba diving and distance running.
Robert Middleberg, PhD
Sr. Vice President, Quality Assurance, Laboratory Director and Forensic Toxicologist, NMS Labs
Robert A. Middleberg is the Laboratory Director and Senior VP of Laboratory Operations and Quality Assurance at NMS Labs. He is a Fellow of the American Board of Forensic Toxicology and a Diplomate of the American Board of Clinical Chemistry, and currently sits as a Board Director of the ABFT and recently completed his tenure on the Board of Directors of ABCC. He served as Toxicology Section Chair within AAFS, and was Chair of the Scientific Working Group in Toxicology from its beginning to its end in 2014. He currently is a member of CAP’s Toxicology Resource Committee, and sits on the Toxicology Subcommittee within the NIST OSAC. In 2013, Dr. Middleberg was awarded the Rolla N. Harger Award by the Toxicology section of the American Academy of Forensic Sciences for his contributions to the field and profession of forensic toxicology.
Lewis S. Nelson, MD, FACMT
Chair of the Department of Emergency Medicine, Rutgers New Jersey Medical School
Lewis S. Nelson, MD is currently Professor and Chair of Emergency Medicine at Rutgers, New Jersey Medical School, in Newark. He is a former President of the American College of Medical Toxicology and has served in various consultative roles with FDA, CDC, and DHS. He is an editor of Goldfrank’s Toxicologic Emergencies, now in its 10th Edition. The focus of his publications and presentations are medication-related adverse effects, chemical terrorism, and toxicity of abused drugs. Until recently, Dr. Nelson was the Director of the Fellowship in Medical Toxicology at New York University School of Medicine.
Jeanmarie Perrone, MD, FACMT
Professor, Emergency Medicine, Perelman School of Medicine Director, Division of Medical Toxicology, Perelman School of Medicine
Dr. Jeanmarie Perrone is the Director of the Division of Medical Toxicology and is a Professor of Emergency Medicine in the Department of Emergency Medicine at the Perelman School of Medicine at the University of Pennsylvania with secondary appointments in Pediatrics and Pathology and Laboratory Medicine. She spends her clinical time caring for patients in the Emergency Department and is a consultant toxicologist for the Philadelphia Poison Center. She has won numerous teaching and mentoring awards for her role with students and residents in emergency medicine. Recently, she has dedicated her efforts to addressing the Prescription Drug Epidemic and studying the impact of opioid prescribing on patients and the community. She has lectured nationally and internationally and published in NEJM and JAMA on strategies to combat opioid misuse. She collaborated on a special CDC sponsored project with the National Association of Medical Examiners and the American College of Medical Toxicology to improve death certification in the setting of drug overdose fatalities. She has served on several pivotal FDA Drug Safety advisory committees identifying efforts to limit the epidemic of prescription drug abuse.
Peter J. Sell, DO, FAAP
Assoc. Prof. of Pediatrics, Division of Critical Care Pediatrics, UMass Medical School
Dr. Sell joined the UMass faculty in 2007 and was Division Chief of Pediatric Hospitalist Medicine in a community hospital setting from 2008-2013. In 2013 Dr. Sell transferred to the main campus of UMass memorial medical Center in the Division of Pediatric Critical Care, and now divides his time between the PICU, Child Protection Program, and (occasionally) Pediatric Emergency Department. In addition to his clinical work, he is an educator with the Clinical Faculty Development Center, the Center for Integrated Primary Care, the UMass Department of Pediatrics, and the Department of Family Medicine at Alpert Medical School. Dr. Sell lectures regionally on various topics, including: general pediatrics, Child Protection and education.
Paul Wax, MD, FACMT
Executive Director; Clinical Professor, ACMT; UT Southwestern
Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
Along with his part time role as the Executive Director of ACMT, Dr. Wax is a Clinical Professor in Surgery (Emergency Medicine) at the University of Texas, Southwestern School of Medicine where he is a member of the Section of Medical Toxicology and Director of the Medical Toxicology Clinic. Before joining ACMT in 2008 as its Executive Director, and the University of Texas Southwestern in 2006 as a part-time faculty member, Dr. Wax had faculty appointments in the Departments of Emergency Medicine at the University of Rochester School of Medicine from 1991-2001 and the University of Arizona School of Medicine from 2001-2006. Dr. Wax previously served on the Board of Directors of ACMT from 1998-2008 serving as ACMT President from 2006-2008. During this tenure he chaired the ACMT Education Committee from 1998-2002. From 2002-2006 Dr. Wax served as the National Director of ACMT's Consultation Network to support the ATSDR Regional Offices and was co-founder of ACMT’s Chemical Agent of Opportunity course. From 1997-2006 Dr. Wax also served as one of the American Board of Emergency Medicine’s appointee’s on the Medical Toxicology Subboard. During this time Dr. Wax served as Editor of the Medical Toxicology Board Certification Examination as well as Chairman of the Subboard, and was also the primary author of the 2004 Core Content of Medical Toxicology. Dr. Wax has also served as a consultant to the Centers for Disease Control NCEH’s Division of Laboratory Sciences and was a member of NCEH/ATSDR Board of Scientific Counselors from 2006-2008.
Tim Wiegand, MD, FACMT
University of Rochester Medical Center
Tim Wiegand MD, DABAM, FACMT, FAACT attended Iowa State University and graduated with Honors and Distinction in 1995. He received his MD from the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin in 2004. Dr. Wiegand completed a categorical Internal Medicine residency at Hennepin County Medical Center, Minneapolis, Minnesota and completed fellowship training in Medical Toxicology and Clinical Pharmacology at the University of California, San Francisco in 2006 and 2007 respectively. Dr. Wiegand also became Board Certified in Addiction Medicine in 2015. He was the Medical Director of the Rochester Poison Center until 2010 and currently serves as the Director of Toxicology and of the Toxicology Consult Service at the University of Rochester Medical Center. Dr. Wiegand is an Associate Clinical Professor in the Department of Emergency Medicine at URMC and also a volunteer faculty member of the SUNY Upstate Medical Toxicology Fellowship program. Dr. Wiegand's research interests include billing, reimbursement and effectiveness of Medical Toxicology practice models, warning signs for suicide attempt in particular the use and involvement of alcohol or drugs in a suicide attempt and he is involved with wide variety of surveillance and research projects involving the bedside toxicology Registry the ACMT Toxic Case Registry.
Garabet “Gary” M. Zakeosian, MD, JD, LLM, FACLM
Medical Malpractice Lawyer, Kline & Specter PC
From 2011-2014 Garabet “Gary” M. Zakeosian, M.D., J.D., LL.M., F.A.C.L.M. was selected as among “The Best Attorneys in Pennsylvania” by Super Lawyers
, the independent rating service whose survey of some 40,000 attorneys and expert panel review determines those attorneys who are in the state’s top five percent.
Dr. Zakeosian received his undergraduate degree from Franklin & Marshall College, earning a B.A. in physics in 1973. He then attended the Milton S. Hershey College of Medicine of the Pennsylvania State University, graduating with an M.D. in 1977. He completed an internship at the Bryn Mawr Hospital and did residency training in anesthesiology at the Hospital of the University of Pennsylvania. He completed post-residency fellowships in pediatric anesthesia and intensive care medicine and in cardiac anesthesia at Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania.
Dr. Zakeosian obtained his board certification in anesthesiology in 1981. He has practiced at Bryn Mawr Hospital, Frankford Hospital and Paoli Memorial Hospital. He has extensive experience with pain management and was co-director of the Frankford Hospital Pain Management Clinic.
Dr. Zakeosian started at Kline & Specter while he was still in law school, doing legal and medical research for cases. He joined the firm full-time after earning his J.D. in 2000 from the University of Pennsylvania. In May 2007 he earned an LL.M. in Trial Advocacy from the Temple University Beasley School of Law, winning the Faculty Award for courtroom performance skills. Dr. Zakeosian is a frequent judge/instructor with the Temple LL.M. program.
He is a member of the Pennsylvania Association for Justice and the Philadelphia Trial Lawyers Association. He is also a Fellow of the American College of Legal Medicine.